Tgfβ restores hematopoietic homeostasis after myelosuppressive chemotherapy

Journal of Experimental Medicine

Volumn 210, Issue 3, 2013, Pages 623-639

  Brenet, Fabienne ^a   Kermani, Pouneh ^a   Spektor, Roman ^a   Rafii, Shahin ^b   Scandura, Joseph M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C; FLUOROURACIL; HEMOGLOBIN; TRANSFORMING GROWTH FACTOR BETA; ANTINEOPLASTIC AGENT; CDKN1C PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW SUPPRESSION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL RENEWAL; CHEMOTHERAPY; CHIMERA; CONTROLLED STUDY; CONVALESCENCE; ERYTHROCYTE COUNT; GENE DELETION; HEMATOCRIT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; LEUKOCYTE COUNT; MEAN CORPUSCULAR VOLUME; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THROMBOCYTE COUNT; UPREGULATION; ANIMAL; BONE MARROW; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW; CYCLIN-DEPENDENT KINASE INHIBITOR P57; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HOMEOSTASIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

MLCS; MLOWN;

EID: 84877607466     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20121610     Document Type: Article

References (71)

1. Annes, J.P., J.S. Munger, and D.B. Rifkin. 2003. Making sense of latent TGFbeta activation. J. Cell Sci. 116:217-224. http://dx.doi.org/10.1242/jcs.00229
2. Barcellos-Hoff, M.H., and T.A. Dix. 1996. Redox-mediated activation of latent transforming growth factor-beta 1. Mol. Endocrinol. 10:1077-1083. http://dx.doi.org/10.1210/me.10.9.1077
3. Batard, P., M.N. Monier, N. Fortunel, K. Ducos, P. Sansilvestri-Morel, T. Phan, A. Hatzfeld, and J.A. Hatzfeld. 2000. TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J. Cell Sci. 113:383-390.
4. Biswas, S., M. Guix, C. Rinehart, T.C. Dugger, A. Chytil, H.L. Moses, M.L. Freeman, and C.L. Arteaga. 2007. Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J. Clin. Invest. 117:1305-1313. http://dx.doi.org/10.1172/JCI30740
5. Blank, U., and S. Karlsson. 2011. The role of Smad signaling in hematopoiesis and translational hematology. Leukemia. 25:1379-1388. http://dx.doi.org/10.1038/leu.2011.95
6. Blank, U., G. Karlsson, J.L. Moody, T. Utsugisawa, M. Magnusson, S. Singbrant, J. Larsson, and S. Karlsson. 2006. Smad7 promotes self-renewal of hematopoietic stem cells. Blood. 108:4246-4254. http://dx.doi.org/10.1182/blood-2006-02-005611
7. Bradford, G.B., B. Williams, R. Rossi, and I. Bertoncello. 1997. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp. Hematol. 25:445-453.
8. Capron, C., C. Lacout, Y. Lécluse, V. Jalbert, H. Chagraoui, S. Charrier, A. Galy, A. Bennaceur-Griscelli, E. Cramer-Bordé, and W. Vainchenker. 2019. A major role of TGF-beta1 in the homing capacities of murine hematopoietic stem cell/progenitors. Blood. 116:1244-1253. http://dx.doi.org/19.1182/blood-2009-05-221993
9. Cheng, T., N. Rodrigues, D. Dombkowski, S. Stier, and D.T. Scadden. 2000a. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat. Med. 6:1235-1240. http://dx.doi.org/19.1938/81335
10. Cheng, T., N. Rodrigues, H. Shen, Y. Yang, D. Dombkowski, M. Sykes, and D.T. Scadden. 2000b. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science. 287:1804-1808. http://dx.doi.org/19.1126/science.287.5459.1804
11. Cheng, T., H. Shen, N. Rodrigues, S. Stier, and D.T. Scadden. 2001. Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1). Blood. 98:3643-3649. http://dx.doi.org/19.1182/blood.V98.13.3643
12. Cheshier, S.H., S.J. Morrison, X. Liao, and I.L. Weissman. 1999. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl. Acad. Sci. USA. 96:3120-3125. http://dx.doi.org/19.1973/pnas.96.6.3120
13. Crawford, S.E., V. Stellmach, J.E. Murphy-Ullrich, S.M. Ribeiro, J. Lawler, R.O. Hynes, G.P. Boivin, and N. Bouck. 1998. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell. 93:1159-1170. http://dx.doi.org/19.1916/S0092-8674(00)81460-9
14. Csaszar, E., D.C. Kirouac, M. Yu, W. Wang, W. Qiao, M.P. Cooke, A.E. Boitano, C. Ito, and P.W. Zandstra. 2012. Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. Cell Stem Cell. 19:218-229. http://dx.doi.org/19.1916/j.stem.2012.01.003
15. Dickson, M.C., J.S. Martin, F.M. Cousins, A.B. Kulkarni, S. Karlsson, and R.J. Akhurst. 1995. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development. 121: 1845-1854.
16. Ehninger, A., and A. Trumpp. 2011. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J. Exp. Med. 208: 421-428. http://dx.doi.org/19.1984/jem.20119132
17. Fortunel, N., J. Hatzfeld, L. Aoustin, P. Batard, K. Ducos, M.N. Monier, A. Charpentier, and A. Hatzfeld. 2000a. Specific dose-response effects of TGF-beta1 on developmentally distinct hematopoietic stem/progenitor cells from human umbilical cord blood. Hematol. J. 1:126-135. http://dx.doi.org/19.1938/sj.thj.6200021
18. Fortunel, N.O., A. Hatzfeld, and J.A. Hatzfeld. 2000b. Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood. 96:2022-2036.
19. Gorelik, L., and R.A. Flavell. 2000. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. 12:171-181. http://dx.doi.org/19.1916/S1974-7613(00)80170-3
20. Heissig, B., K. Hattori, S. Dias, M. Friedrich, B. Ferris, N.R. Hackett, R.G. Crystal, P. Besmer, D. Lyden, M.A. Moore, et al. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 199:625-637. http://dx.doi.org/19.1916/S0092-8674(02)00754-7
21. Iwata, J.-I., J.G. Hacia, A. Suzuki, P.A. Sanchez-Lara, M. Urata, and Y. Chai. 2012. Modulation of noncanonical TGF-β signaling preventscleft palate in Tgfbr2 mutant mice. J. Clin. Invest. 122:873-885. http://dx.doi.org/19.1172/JCI61498
22. Karlsson, G., U. Blank, J.L. Moody, M. Ehinger, S. Singbrant, C.X. Deng, and S. Karlsson. 2007. Smad4 is critical for self-renewal of hematopoietic stem cells. J. Exp. Med. 204:467-474. http://dx.doi.org/19.1984/jem.20060465
23. Kiel, M.J., O.H. Yilmaz, T. Iwashita, O.H. Yilmaz, C. Terhorst, and S.J. Morrison. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 121:1199-1121. http://dx.doi.org/19.1916/j.cell.2005.05.026
24. Kollet, O., A. Dar, S. Shivtiel, A. Kalinkovich, K. Lapid, Y. Sztainberg, M. Tesio, R.M. Samstein, P. Goichberg, A. Spiegel, et al. 2006. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12:657-664. http://dx.doi.org/19.1938/nm1417
25. Kopp, H.G., S.T. Avecilla, A.T. Hooper, S.V. Shmelkov, C.A. Ramos, F. Zhang, and S. Rafii. 2005. Tie2 activation contributes to hemangiogenic regeneration after myelosuppression. Blood. 196:505-513. http://dx.doi.org/19.1182/blood-2004-11-4269
26. Lapidot, T., and I. Petit. 2002. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30:973-981. http://dx.doi.org/19.1916/S0301-472X(02)00883-4
27. Larsson, J., M.J. Goumans, L.J. Sjöstrand, M.A. van Rooijen, D. Ward, P. Levéen, X. Xu, P. ten Dijke, C.L. Mummery, and S. Karlsson. 2001. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 20:1663-1673. http://dx.doi.org/19.1993/emboj/20.7.1663
28. Larsson, J., U. Blank, H. Helgadottir, J.M. Björnsson, M. Ehinger, M.J. Goumans, X. Fan, P. Levéen, and S. Karlsson. 2003. TGF-beta signalingdeficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. Blood. 192:3129-3135. http://dx.doi.org/19.1182/blood-2003-04-1300
29. Larsson, J., U. Blank, J. Klintman, M. Magnusson, and S. Karlsson. 2005. Quiescence of hematopoietic stem cells and maintenance of the stem cell pool is not dependent on TGF-beta signaling in vivo. Exp. Hematol. 33:592-596. http://dx.doi.org/19.1916/j.exphem.2005.02.003
30. Letterio, J.J., A.G. Geiser, A.B. Kulkarni, H. Dang, L. Kong, T. Nakabayashi, C.L. Mackall, R.E. Gress, and A.B. Roberts. 1996. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98:2199-2119. http://dx.doi.org/19.1172/JCI119017
31. Levéen, P., J. Larsson, M. Ehinger, C.M. Cilio, M. Sundler, L.J. Sjöstrand, R. Holmdahl, and S. Karlsson. 2002. Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood. 190:560-568. http://dx.doi.org/19.1182/blood.V190.2.560
32. Lévesque, J.P., and I.G. Winkler. 2011. Hierarchy of immature hematopoietic cells related to blood flow and niche. Curr. Opin. Hematol. 18:220- 225. http://dx.doi.org/19.1997/MOH.0b013e3283475fe7
33. Lévesque, J.P., J. Hendy, Y. Takamatsu, P.J. Simmons, and L.J. Bendall. 2003. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111:187-196.
34. Matsumoto, A., S. Takeishi, T. Kanie, E. Susaki, I. Onoyama, Y. Tateishi, K. Nakayama, and K.I. Nakayama. 2011. p57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell. 9:262- 271. http://dx.doi.org/19.1916/j.stem.2011.06.014
35. McCulloch, E.A. 2002. CFU-S. In Hematopoietic Stem Cell Protocols. C.A. Klug, and C.T. Jordan, editors. Humana Press, Inc., Totowa, NJ. 153-160.
36. Miyamoto, K., K.Y. Araki, K. Naka, F. Arai, K. Takubo, S. Yamazaki, S. Matsuoka, T. Miyamoto, K. Ito, M. Ohmura, et al. 2007. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell. 1:191-112. http://dx.doi.org/19.1916/j.stem.2007.02.001
37. Morrison, S.J., D.E. Wright, and I.L. Weissman. 1997. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc. Natl. Acad. Sci. USA. 94:1908- 1913. http://dx.doi.org/19.1973/pnas.94.5.1908
38. Mu, D., S. Cambier, L. Fjellbirkeland, J.L. Baron, J.S. Munger, H. Kawakatsu, D. Sheppard, V.C. Broaddus, and S.L. Nishimura. 2002. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J. Cell Biol. 157:493-507. http://dx.doi.org/10.1083/jcb.200109100
39. Munger, J.S., J.G. Harpel, F.G. Giancotti, and D.B. Rifkin. 1098. Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1. Mol. Biol. Cell. 9:2627-2638.
40. Munger, J.S., X. Huang, H. Kawakatsu, M.J. Griffiths, S.L. Dalton, J. Wu, J.F. Pittet, N. Kaminski, C. Garat, M.A. Matthay, et al. 1099. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 96:319-328. http://dx.doi.org/10.1016/S0092-8674(00)80545-0
41. Muraoka, R.S., N. Dumont, C.A. Ritter, T.C. Dugger, D.M. Brantley, J. Chen, E. Easterly, L.R. Roebuck, S. Ryan, P.J. Gotwals, et al. 2002. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Invest. 109:1551-1559.
42. Oshima, M., H. Oshima, and M.M. Taketo. 1096. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179:297-302. http://dx.doi.org/10.1006/dbio.1996.0259
43. Passegué, E., A.J. Wagers, S. Giuriato, W.C. Anderson, and I.L. Weissman. 2005. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J. Exp. Med. 202:1599-1611. http://dx.doi.org/10.1084/jem.20050967
44. Petit, I., M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, L. Habler, T. Ponomaryov, R.S. Taichman, F. Arenzana-Seisdedos, N. Fujii, et al. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3:687-694. http://dx.doi.org/10.1038/ni813
45. Pfeilschifter, J., I. Diel, B. Scheppach, A. Bretz, R. Krempien, J. Erdmann, G. Schmid, N. Reske, H. Bismar, T. Seck, et al. 1098. Concentration of transforming growth factor beta in human bone tissue: relationship to age, menopause, bone turnover, and bone volume. J. Bone Miner. Res. 13:716-730. http://dx.doi.org/10.1359/jbmr.1998.13.4.716
46. Qian, H., N. Buza-Vidas, C.D. Hyland, C.T. Jensen, J. Antonchuk, R. Månsson, L.A. Thoren, M. Ekblom, W.S. Alexander, and S.E. Jacobsen. 2007. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell. 1:671-684. http://dx.doi.org/10.1016/j.stem.2007.10.008
47. Ribeiro, S.M., M. Poczatek, S. Schultz-Cherry, M. Villain, and J.E. Murphy-Ullrich. 1099. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J. Biol. Chem. 274:13586-13593. http://dx.doi.org/10.1074/jbc.274.19.13586
48. Sato, Y., R. Tsuboi, R. Lyons, H. Moses, and D.B. Rifkin. 1990. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J. Cell Biol. 111:757-763. http://dx.doi.org/10.1083/jcb.111.2.757
49. Scandura, J.M., P. Boccuni, J. Massagué, and S.D. Nimer. 2004. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc. Natl. Acad. Sci. USA. 101:15231-15236. http://dx.doi.org/10.1073/pnas.0406771101
50. Schaefer, B.C., M.L. Schaefer, J.W. Kappler, P. Marrack, and R.M. Kedl. 2001. Observation of antigen-dependent CD8+ T-cell/dendritic cell interactions in vivo. Cell. Immunol. 214:110-122. http://dx.doi.org/10.1006/cimm.2001.1895
51. Sitnicka, E., F.W. Ruscetti, G.V. Priestley, N.S. Wolf, and S.H. Bartelmez. 1096. Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood. 88:82-88.
52. Takahashi, K., K. Nakayama, and K. Nakayama. 2000. Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation. J. Biochem. 127:73-83. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a022586
53. Tang, Y., X. Wu, W. Lei, L. Pang, C. Wan, Z. Shi, L. Zhao, T.R. Nagy, X. Peng, J. Hu, et al. 2009. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 15:757-765. http://dx.doi.org/10.1038/nm.1979
54. Tesio, M., and A. Trumpp. 2011. Breaking the cell cycle of HSCs by p57 and friends. Cell Stem Cell. 9:187-192. http://dx.doi.org/10.1016/j.stem.2011.08.005
55. Wilson, A., and A. Trumpp. 2006. Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol. 6:93-106. http://dx.doi.org/10.1038/nri1779
56. Wilson, A., E. Laurenti, G. Oser, R.C. van der Wath, W. Blanco-Bose, M. Jaworski, S. Offner, C.F. Dunant, L. Eshkind, E. Bockamp, et al. 2008. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 135:1118-1129. http://dx.doi.org/10.1016/j.cell.2008.10.048
57. Wu, X., L. Pang, W. Lei, W. Lu, J. Li, Z. Li, F.J. Frassica, X. Chen, M. Wan, and X. Cao. 2010. Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell. 7:571-580. http://dx.doi.org/10.1016/j.stem.2010.09.012
58. Yamazaki, S., A. Iwama, S. Takayanagi, Y. Morita, K. Eto, H. Ema, and H. Nakauchi. 2006. Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J. 25:3515-3523. http://dx.doi.org/10.1038/sj.emboj.7601236
59. Yamazaki, S., A. Iwama, S. Takayanagi, K. Eto, H. Ema, and H. Nakauchi. 2009. TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood. 113:1250-1256. http://dx.doi.org/10.1182/blood-2008-04-146480
60. Yamazaki, S., H. Ema, G. Karlsson, T. Yamaguchi, H. Miyoshi, S. Shioda, M.M. Taketo, S. Karlsson, A. Iwama, and H. Nakauchi. 2011. Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell. 147:1146-1158. http://dx.doi.org/10.1016/j.cell.2011.09.053
61. Yan, Y., J. Frisén, M.H. Lee, J. Massagué, and M. Barbacid. 1097. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11:973-983.
62. Yang, Y.-A., O. Dukhanina, B. Tang, M. Mamura, J.J. Letterio, J. MacGregor, S.C. Patel, S. Khozin, Z.-Y. Liu, J. Green, et al. 2002. Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects. J. Clin. Invest. 109:1607-1615.
63. Yang, Z., Z. Mu, B. Dabovic, V. Jurukovski, D. Yu, J. Sung, X. Xiong, and J.S. Munger. 2007. Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J. Cell Biol. 176:787-793. http://dx.doi.org/10.1083/jcb.200611044
64. Yaswen, L., A.B. Kulkarni, T. Fredrickson, B. Mittleman, R. Schiffman, S. Payne, G. Longenecker, E. Mozes, and S. Karlsson. 1096. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood. 87:1439-1445.
65. Yilmaz, O.H., M.J. Kiel, and S.J. Morrison. 2006. SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity. Blood. 107:924-930. http://dx.doi.org/10.1182/blood-2005-05-2140
66. Yingling, J.M., K.L. Blanchard, and J.S. Sawyer. 2004. Development of TGF-beta signalling inhibitors for cancer therapy. Nat. Rev. Drug Discov. 3:1011-1022. http://dx.doi.org/10.1038/nrd1580
67. Yoshihara, H., F. Arai, K. Hosokawa, T. Hagiwara, K. Takubo, Y. Nakamura, Y. Gomei, H. Iwasaki, S. Matsuoka, K. Miyamoto, et al. 2007. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell. 1:685-697. http://dx.doi.org/10.1016/j.stem.2007.10.020
68. Yu, Q., and I. Stamenkovic. 2000. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14:163-176.
69. Yuan, Y., H. Shen, D.S. Franklin, D.T. Scadden, and T. Cheng. 2004. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat. Cell Biol. 6:436-442. http://dx.doi.org/10.1038/ncb1126
70. Zhang, P., N.J. Liégeois, C. Wong, M. Finegold, H. Hou, J.C. Thompson, A. Silverman, J.W. Harper, R.A. DePinho, and S.J. Elledge. 1097. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature. 387:151-158. http://dx.doi.org/10.1038/387151a0
71. Zou, P., H. Yoshihara, K. Hosokawa, I. Tai, K. Shinmyozu, F. Tsukahara, Y. Maru, K. Nakayama, K.I. Nakayama, and T. Suda. 2011. p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell. 9:247-261. http://dx.doi.org/10.1016/j.stem.2011.07.003